Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
Status:
Recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
AR-301 is being evaluated as an adjunctive treatment of ventilator-associated pneumonia (VAP)
due to Staphylococcus aureus (S. aureus) in combination with standard of care (SOC)
antibiotic therapy in patients with confirmed S. aureus infection.